Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Barbara Raskay"'
Autor:
Theodore G. Krontiris, Robert C. Elston, John C. Ruckdeschel, David Johnson, Jae Werndli, James A. Stewart, Rosalind Drew, Rebecca Sutphen, Barbara Raskay, Peter J. O'Dwyer, John M. Kirkwood, Kimberly Smith, Al B. Benson, Irene Angel, Mary B. Daly, Donna Neuberg, Jerry Slater, John Archambeau, Deborah MacDonald, Jeffrey Weitzel, Louis Geller, Guillermo Rivas, Virgil Gagalang, Cathryn Lundberg, Li S-C. Cheng, Yan Ding, Garry P. Larson
Supplementary Figure from Genetic Linkage of Prostate Cancer Risk to the Chromosome 3 Region Bearing FHIT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137bc77dd0f71695e504f0b6db22926c
https://doi.org/10.1158/0008-5472.22364364
https://doi.org/10.1158/0008-5472.22364364
Autor:
Theodore G. Krontiris, Robert C. Elston, John C. Ruckdeschel, David Johnson, Jae Werndli, James A. Stewart, Rosalind Drew, Rebecca Sutphen, Barbara Raskay, Peter J. O'Dwyer, John M. Kirkwood, Kimberly Smith, Al B. Benson, Irene Angel, Mary B. Daly, Donna Neuberg, Jerry Slater, John Archambeau, Deborah MacDonald, Jeffrey Weitzel, Louis Geller, Guillermo Rivas, Virgil Gagalang, Cathryn Lundberg, Li S-C. Cheng, Yan Ding, Garry P. Larson
We conducted linkage analysis of 80 candidate genes in 201 brother pairs affected with prostatic adenocarcinoma. Markers representing two adjacent candidate genes on chromosome 3p, CDC25A and FHIT, showed suggestive evidence for linkage with single-p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803e1cac09d7eadf6a99c0fbefdd310a
https://doi.org/10.1158/0008-5472.c.6494157.v1
https://doi.org/10.1158/0008-5472.c.6494157.v1
Autor:
Peter J. O'Dwyer, Fran Green, Roland Alexander, Barbara Raskay, Paul F. Engstrom, Istvan Redei, Stephen Fox, Kweku Amfoh, Charles J. Lusch, Richard Scher, R Kosierowski
Publikováno v:
Investigational new drugs. 13(4)
A phase II trial of topotecan, an inhibitor of topoisomerase I, was conducted in patients with advanced or metastatic adenocarcinoma of the pancreas to determine the activity and toxicity of topotecan. 35 patients, previously untreated with chemother